Drug Database
Back to search

Netherlands· NL-a361e32d1432

Graphites

A medicinal product containing graphites + graphites + graphites + graphites, registered in Netherlands by Heel Belgium n.v..

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedGraphitesATC—REGISTER NO.NL-a361e32d1432PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about graphites + graphites + graphites + graphitesAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

The record

At a glance

CBG-MEB (Netherlands)
Active substance
GRAPHITES + GRAPHITES + GRAPHITES + GRAPHITES
Manufacturer
Heel Belgium n.v.
Country
Netherlands (NL)
ATC code
—
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    93569

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Graphites + graphites + graphites + graphites in 10 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All graphites + graphites + graphites + graphites products

Authorised across Europe · EMA

The same active substance is authorised in 21 EEA countries. Names it is sold under:

  • Austria · Pulmotec
  • Belgium · Pulmotec
  • Czechia · Pulfunvu
  • Germany · Pulmotec
  • Denmark · Pulmotec
  • Spain · Pulmotec
  • Finland · Pulmotec
  • France · Pulmotec
  • United Kingdom (Northern Ireland) · Pulmotec
  • Greece · Pulmotec
  • Croatia · Pulmotec
  • Hungary · Pulmotec
  • Ireland · Pulmotec
  • Iceland · Pulmotec
  • Italy · Pulmotec
  • Luxembourg · Pulmotec
  • Norway · Pulmotec
  • Poland · Respiriscint
  • Portugal · Pulmotec
  • Sweden · Pulmotec
  • Slovakia · Carbotech

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/a8b47e98-6f87-4cfb-96ea-ccc0b36052cb
GET /v1/drugs/a8b47e98-6f87-4cfb-96ea-ccc0b36052cb?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": null,
  "route": "Oraal gebruik",
  "soort": "RVH",
  "source": "cbg_meb",
  "smpc_url": null,
  "strength": null,
  "atc_label": null,
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg93569",
  "excipients": null,
  "substances": [
    "GRAPHITES",
    "GRAPHITES",
    "GRAPHITES",
    "GRAPHITES"
  ],
  "leaflet_url": null,
  "authorised_at": "2006/11/09",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend apotheek of drogist",
  "registration_number": "93569",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about graphites + graphites + graphites + graphites.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console